Ann: LBT Strengthens APAS Pharma Development, page-4

So, TF is paying us to make APAS Pharma work on TF media. Control the device and consumables.
In parallel, a multinational pharmaceutical company (I'm going to assume BigPharma) wants us on their own project.
BioPhorum doesn't get a mention here.
On 14th September this year, LBT reported on their presentation to BioPhorum's Alternative & Rapid Microbiology Methods working group and the successful proof-of-concept. It appears to me that BigPharma has taken on the next stage of the APAS Pharma project on a go-alone basis. However the intel from a successful partnership with LBT would be shared with the BioPhorum membership. The collaboration of multinational pharmaceutical companies that make up BioPhorum control approximately 60% of the global market. Most of that is in the US, of course.

So is BigPharma/BioPhorum doing the regulatories with LBT to then, if successful, hand the shelf-ready Modules to Thermo Fisher to sell to them?
What else would a MNC pharmaceutical want out of APAS Pharma?

GLTAH